Rochelle Wilson
Pediatric Endocrinology · Phoenix, AZNPI 1801189691
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,297 of the $4,452 with a category attached, or 74.0%. 26 manufacturers reported payments, led by Tandem Diabetes Care, Inc. at 39.8% of the total. Reporting peaked in 2024 at $2,105 and has fallen 79.9% since, to $423 in 2025.
Across 131 payments — averaging $33.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$2K
- Pfizer$369
- BETA Bionics, Inc.$278
- Novo Nordisk$215
- Ascendis Pharma Endocrinology Inc$201
- Rhythm Pharmaceuticals, Inc.$190
- plus $1K from 20 others
What the payments were for
- Travel & lodging$1,11325%
- Food & beverage$3,29774%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 17 | $1,772 |
| Pfizer | 22 | $369 |
| BETA Bionics, Inc. | 5 | $278 |
| Novo Nordisk | 14 | $215 |
| Ascendis Pharma Endocrinology Inc | 6 | $201 |
| Rhythm Pharmaceuticals, Inc. | 4 | $190 |
| AbbVie | 9 | $155 |
| Medtronic(2 entities) | 7 | $146 |
| Sanofi-aventis U.S. LLC | 2 | $138 |
| Xeris Pharmaceuticals, Inc. | 7 | $123 |
| Tolmar Pharmaceuticals, Inc. | 4 | $107 |
| Lilly USA, LLC | 7 | $103 |
| Dexcom, Inc. | 6 | $102 |
| Ascensia Diabetes Care US Inc. | 1 | $98 |
| Arbor Pharmaceuticals, Inc. | 4 | $84 |
| Insulet Corporation | 4 | $83 |
| Sequel Med Tech, LLC | 1 | $71 |
| Ultragenyx Pharmaceutical Inc. | 2 | $44 |
| Abbott | 2 | $37 |
| Intuity Medical Inc | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Companion Medical, Inc. | 1 | $17 |
| Eton Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$1,515
- iLet Bionic Pancreas$713
- Imcivree$125
- TZIELD$122
How this compares
$4,452 in reported general payments places this provider in the 70th percentile of 35 pediatric endocrinology providers in Arizona.
Other pediatric endocrinology in Phoenix
- Eileen Baez IrizarryPhoenix$53K
- Pamela SmithPhoenix$26K
- Chirag KapadiaPhoenix$13K
- Grazyna Piekos-SobczakPhoenix$12K
- Rola SaadPhoenix$10K
- Micah OlsonPhoenix$9K
- Amanda CamposPhoenix$3K
- Mahmoud KabbaniPhoenix$3K
- Melissa ChambersPhoenix$3K
- Dorothee NewbernPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.